Capsule Endoscopy Market Trends

Capsule Endoscopy Market Driver

The global market for capsule endoscopy is projected to be driven by the increasing technical developments in endoscopic treatments.

• The range of applications for capsule endoscopy systems, including those for colon disease, small bowel disease, and esophageal illness, has increased due to technological developments. Technological advancements have enhanced the traditional endoscopy's diagnostic, monitoring, and viewing capabilities. New varieties of capsule endoscopes, including those for the small intestine, colon, and oesophagus, have been developed as a result of advanced technologies. Product manufacturers are also developing user-friendly and high-resolution cameras with a 360-degree panoramic view. Endoscopy now has a high level of accuracy, safety, and precision thanks to advancements that would have been difficult to attain only a few years ago. The video scope and the capsule endoscope have replaced the fibreoptic endoscope (fiberscope) period recently. Also, in November, 2021, PillCam Small Bowel 3 system for remote endoscopy procedures. With the use of Amazon logistics and Medtronic's PillCam technology, the PillCam SB3 @HOME programme aims to give patients access to rapid, reliable results from the convenience of their own homes. The telehealth option PillCam SB3 @HOME allows for direct vision and monitoring of the small bowel. It can assist in identifying lesions that are missed by upper and lower endoscopy and may: indicate Crohn's disease, find hidden bleeding, or reveal the causes of iron deficiency anaemia (IDA).

Capsule Endoscopy Market Restraint

Limitations related to the application of capsule endoscopy are projected to restrain market expansion.

• The market expansion of capsule endoscopy is hampered by some of its limitations, such as capsule retention and utilisation restricted to diagnostic purposes. Endoscopic retrieval or surgical excision may be necessary to reduce the chance of capsule retention. For instance, a study published in Annals of Translational Medicine found that about 2% of patients undergoing a small bowel capsule endoscopic surgery had capsule retention. This makes the use of capsule endoscopes difficult. Also, problems in some sections of the intestine are ignored due to the capsule's fast transit and blurry, unreadable images. Images may be distorted by food or stool residue. The main danger of capsule endoscopy is small bowel device retention. Patients who undergo the test to check for bleeding run a very low risk—between one and two percent—of bleeding. Patients with Crohn's disease may see a four to five percent increase in risk. However, it is projected that the retention rate would decrease with technology developments and better designed wireless capsules, which will spur the capsule endoscopy market expansion.